Business
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research
POTOMAC, MD / ACCESS Newswire / February 26, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, today announced the filing of utility patent ...
About this update from Igc Pharma, Inc.
[{"type":"text","content":"POTOMAC, MD / ACCESS Newswire / February 26, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, today announced the filing of utility patent applications covering the architectural framework of its Agentic Harmonization Assistant ("AHA"), an internally developed AI-based data harmonization system.","length":439,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"IGC Pharma, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1504,"height":890,"url":"https://media.zenfs.com/en/accesswire.ca/e8ebe63cd2b1e57a453c16f45fd96ee2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iNZKMhTYn3AOvPxoebNhXA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2ODtjZj13ZWJw/https://media.zenfs.com/en/accesswire.ca/e8ebe63cd2b1e57a453c16f45fd96ee2","width":960,"height":568},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/5E6lBZL4A47zd3CIMNjOqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNDIwO2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/e8ebe63cd2b1e57a453c16f45fd96ee2","width":1200,"height":710}},"href":"https://app.accessnewswire.com/imagelibrary/365d1260-18b0-42c6-9a6f-16f920cf9f1e/igc-pharma-inc-2025.png","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"IGC is developing AHA to support the standardization of heterogeneous Alzheimer's disease datasets, which often vary significantly in schema definitions, variable encodings, and data structures. These inconsistencies can limit cross-cohort analysis and slow both clinical research and AI model development. AHA is being designed as a structured, multi-stage agentic architecture intended to automate dataset alignment and validation across diverse Alzheimer's datasets. The Company has harmonized 15 Alzheimer's-related datasets for internal development purposes and continues to refine the system architecture.","length":623,"tagName":"p"},{"type":"text","content":"Earlier this year, AHA advanced to the semi-final round of a competitive AI research evaluation program. The Company plans to present additional details regarding AHA's development roadmap at the upcoming ADPD conference.","length":225,"tagName":"p"},{"type":"text","content":"The filed utility patent applic...